Duarte, Susana, and V. Cruz-Machado. "
Green and lean model for business sustainability."
Proceedings of the 10th International Conference on Management Science and Engineering Management. Vol. 502. Advances in Intelligent Systems and Computing, 502. Springer-Verlag, 2017. 1281-1291.
AbstractUnderstanding how efficiently we use the role of resources in the organization namely natural resources in use, water, materials and energy consumption is a vital step for designing business strategies to tackle inefficiencies. Green and lean model for business sustainability will be presented and indicators for a resource efficient and green business will be discussed. Organizations must understand how resources are use and how can be used, making better decision about the use of those environmental, social, and economic resources. However the resources are not only a business concern. All organizations in a specific region should be evaluated for the knowledge of the progress on the road to sustainability. This study aims to be a preliminary study of how to use green and lean management concept as a step towards to sustainability. To the authors this is the first attempt to understand and develop a model through green and lean concepts to improve critical sustainability issues, enhancing the efficiency of the resources.
Angione, Giacomo, José Barbosa, Frederik Gosewehr, Paulo Leitão, Daniele Massa, João Matos, Ricardo Silva Peres, André Dionisio Rocha, and Jeffrey Wermann. "
Integration and Deployment of a Distributed and Pluggable Industrial Architecture for the PERFoRM Project."
27th International Conference on Flexible Automation and Intelligent Manufacturing, FAIM2017. Vol. 11. 2017. 896-904.
Abstractn/a
Duarte, Rui M., Pedro Varanda, Rui L. Reis, Ana Rita C. Duarte, and Jorge Correia-Pinto. "
{Biomaterials and Bioactive Agents in Spinal Fusion}."
Tissue Engineering Part B: Reviews. 23 (2017): ten.teb.2017.0072.
AbstractManagement of degenerative spine pathologies frequently leads to the need for spinal fusion (SF), where bone growth is induced toward stabilization of the interventioned spine. Autologous bone graft (ABG) remains the gold-standard inducer, whereas new bone graft substitutes attempt to achieve effective de novo bone formation and solid fusion. Limited fusion outcomes have driven motivation for more sophisticated and multidisciplinary solutions, involving new biomaterials and/or biologics, through innovative delivery platforms. The present review will analyze the most recent body of literature that is focused on new approaches for consistent bone fusion of spinal vertebrae, including the development of new biomaterials that pursue physical and chemical aptitudes; the delivery of growth factors (GF) to accelerate new bone formation; and the use of cells to improve functional bone development. Bone graft substitutes currently in clinical practice, such as demineralized bone matrix and ceramics, are still used as a starting point for the study of new bioactive agents. Polyesters such as polycaprolactone and polylactic acid arise as platforms for the development of composites, where a mineral element and cell/GF constitute the delivery system. Exciting fusion outcomes were obtained in several small and large animal models with these. On what regards bioactive agents, mesenchymal stem cells, preferentially derived from the bone marrow or adipose tissue, were studied in this context. Autologous and allogeneic approaches, as well as osteogenically differentiated cells, have been tested. These cell sources have further been genetically engineered for specific GF expression. Nevertheless, results on fusion efficacy with cells have been inconsistent. On the other hand, the delivery of GF (most commonly bone morphogenetic protein-2 [BMP-2]) has provided favorable outcomes. Complications related to burst release and dosing are still the target of research through the development of controlled release systems or alternative GF such as Nel-like molecule-1 (NELL-1), Oxysterols, or COMP-Ang1. Promising solutions with new biomaterial and GF compositions are becoming closer to the human patient, as these evidence high-fusion performance, while offering cost and safety advantages. The use of cells has not yet proved solid benefits, whereas a further understanding of cell behavior remains a challenge.
Pohl, Randolf, Fran{\c c}ois Nez, Luis M. P. Fernandes, Marwan Abdou Ahmed, Fernando D. Amaro, Pedro Amaro, Fran{\c c}ois Biraben, João M. R. Cardoso, Daniel S. Covita, Andreas Dax, Satish Dhawan, Marc Diepold, Beatrice Franke, Sandrine Galtier, Adolf Giesen, Andrea L. Gouvea, Johannes Götzfried, Thomas Graf, Theodor W. Hänsch, Malte Hildebrandt, Paul Indelicato, Lucile Julien, Klaus Kirch, Andreas Knecht, Paul Knowles, Franz Kottmann, Julian J. Krauth, Eric-Olivier Le Bigot, Yi-Wei Liu, José A. M. Lopes, Livia Ludhova, Jorge Machado, Cristina M. B. Monteiro, Fran{\c c}oise Mulhauser, Tobias Nebel, Paul Rabinowitz, Joaquim M. F. dos Santos, José Paulo Santos, Lukas A. Schaller, Karsten Schuhmann, Catherine Schwob, Csilla I. Szabo, David Taqqu, João F. C. A. Veloso, Andreas Voss, Birgit Weichelt, and Aldo Antognini. "
{Laser Spectroscopy of Muonic Atoms and Ions}."
Proceedings of the 12th International Conference on Low Energy Antiproton Physics (LEAP2016). Journal of the Physical Society of Japan, 2017.
Abstractn/a